Randomized, Controlled Trial of Kangaroo Mother Care in Increasing the Rate of Weight Gain Among Neonates
A Randomized, Controlled Trial of Kangaroo Mother Care in Increasing the Rate of Weight Gain Among Low Birth Weight Neonates Admitted in Level II Neonatal Intensive Care Unit of the Philippine General Hospital
1 other identifier
interventional
52
1 country
1
Brief Summary
A randomized, controlled trial of Kangaroo Mother Care (KMC) to determine the effectiveness in increasing the rate of weight gain among low birth weight neonates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Sep 2011
Shorter than P25 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 6, 2014
CompletedFirst Posted
Study publicly available on registry
March 12, 2014
CompletedMarch 12, 2014
March 1, 2014
1.3 years
March 6, 2014
March 10, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Low Birth Weight
Low-birth weight infants both in the intervention and control group were discharged from the study according to the following criteria: baby's general health was good as assessed by the attending physician and in evidence of infection, feeding well and receiving exclusively breast milk, gaining weight (at least 15-20 grams/kg/day for at least 3 days), maintaining body temperature satisfactorily for at least 3 consecutive days in room temperature and the mother and family members were confident to take care of the baby in KMC.
3 days
Study Arms (2)
Kangaroo Mother Care Group
OTHERMothers in the KMC group were oriented in detail about KMC procedure. The mothers provided skin to skin contact using a specially tailored "kangaroo tube" made of soft flannel cloth. The mothers were encouraged to keep the baby in KMC as long as possible during the day and night for an accumulated time of at least 6 hours per day. The duration of the kangaroo care by each of the mother were recorded and tallied accordingly.
Conventional Mother Care
OTHERConventional method of care was the routine care offered in the neonatal unit to low birth weight infants.
Interventions
The infants were placed on continuous skin to skin contact between the mother and the baby as soon as possible. The mother kept her newborn infant between the breast, in close contact with her body and covered with the kangaroo tube. Infants wore diaper and a cap during the procedure. Breastfeeding was the standard feeding method. When the baby was not in KMC, the baby was placed in the bassinet under warm lamp, if needed, adequately clothed and covered.
This is generally included: an artificial warming system (heated room overhead lamp warmers). Breastfeeding was also the standard feeding method but if indicated, babies can also be fed through tube or cup feeding. The mothers were allowed to visit their babies anytime but skin to skin contact was not allowed. Babies in both groups were monitored hourly. Their heart rate, respiratory rate and temperature were monitored and recorded. Any untoward events like hypothermia, hypoglycemia, apnea, signs of sepsis, and feeding problems were also noted.
Eligibility Criteria
You may qualify if:
- birth weight \<1500 grams and stable neonates (no dependency on oxygen and /or intravenous fluid, ability (at least partial) to feed) with stable vital signs for the past 24 hours (normal temperature (36.5-37.5 °C),
- normal heart rate (120-160 bpm), normal blood pressure per age
- no apnea
- no intravenous lines or with well-secured peripheral line
- no sepsis
- no emerging signs of sepsis
- on IV antibiotic therapy but clinically stable
- can require photo therapy but with stable and not rising total serum bilirubin (TSB) level or TSB is not in high risk zone.
You may not qualify if:
- neonates with chromosomal and life threatening congenital anomalies, who were severally ill
- whose mothers are critically ill and whose mothers were unable to comply with the follow up schedule.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of the Philippineslead
- Pfizercollaborator
Study Sites (1)
Philippine General Hospital - University of the Philippines Manila
Manila, National Capital Region, 1000, Philippines
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Faye S De Ocampo, Medical Doctor
Department of Pediatrics College of Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2014
First Posted
March 12, 2014
Study Start
September 1, 2011
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
March 12, 2014
Record last verified: 2014-03